CorWave

CorWave is a French startup that specializes in developing and manufacturing innovative implantable blood pumps using a breakthrough membrane technology. The company's wave membrane pump sets itself apart from existing left ventricular assist devices (LVADs) by mimicking the physiological operation and blood flow rates of a healthy heart. This unique approach is expected to minimize complications associated with current devices and enhance the management of heart failure patients.

Founded in 2012 and headquartered in France, CorWave has received substantial support from notable investors such as Bpifrance, Vlerick Group, and EXOR N.V. The company's recent Series C investment amounting to €26.00M on 20 June 2023 signifies a strong vote of confidence from investors. As a member of the French Tech 120, CorWave has secured over €80 million in equity and currently employs more than seventy individuals.

CorWave's innovative approach to cardiac assist devices and their impressive financial backing make them a compelling player in the Health Care, Manufacturing, and Medical Devices industries. Their potential to disrupt the market and provide better solutions for heart failure patients positions them as a promising investment opportunity.